SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0000950109-03-002357
Filing Date
2003-04-25
Accepted
2003-04-25 15:24:08
Documents
6

Document Format Files

Seq Description Document Type Size
1 FILED PURSUANT TO RULE 425 d425.htm 425 16419
3 GRAPHIC g54557calander.gif GRAPHIC 5134
4 GRAPHIC g54557computer.gif GRAPHIC 6856
5 GRAPHIC g54557enzon.jpg GRAPHIC 11793
6 GRAPHIC g54557integration.gif GRAPHIC 11171
7 GRAPHIC g54557nps.jpg GRAPHIC 9447
  Complete submission text file 0000950109-03-002357.txt   63239
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filed by) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Subject) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-23272 | Film No.: 03664629
SIC: 2836 Biological Products, (No Diagnostic Substances)